This inventor holds 1 USPTO granted patent and 6 published patent applications. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: **Jennifer Maloney: Innovator in Pain Management**
Introduction
Jennifer Maloney, an accomplished inventor located in Hastings-on-Hudson, NY, has made significant strides in the field of pharmaceutical science. With her innovative approach to pain management, particularly concerning knee and hip pain, she has garnered attention for her contributions to medicine.
Latest Patents
Maloney holds a patent for a groundbreaking pharmaceutical composition aimed at the safe and effective treatment of knee and/or hip pain. This patent details a method for treating patients who are non-responsive or intolerant to standard analgesic therapy. Additionally, it highlights a method for reducing the risk of developing arthropathy in subjects receiving an anti-NGF antibody for knee and/or hip pain treatment. The patent includes methods for monitoring the safety of treatment plans that involve the administration of an anti-NGF antibody, specifically focusing on subjects with osteoarthritis of the knee and/or hip, where fasinumab is utilized.
Career Highlights
Currently, Jennifer Maloney works at Regeneron Pharmaceuticals, Inc., where she continues to push the boundaries of pharmaceutical innovation. Her research and commitment to enhancing patient care reflect her dedication to the field. Maloney's patent signifies not only her expertise but also her impact on developing new therapeutic options for individuals suffering from chronic pain.
Collaborations
Throughout her career, Maloney has collaborated with notable colleagues, including Gregory P. Geba and Paula Dakin. These partnerships have contributed to her success and the advancement of projects aimed at improving treatment methodologies in pain management.
Conclusion
In summary, Jennifer Maloney represents the forefront of innovation in the pharmaceutical realm, particularly in managing knee and hip pain. Her patent underscores the potential for new treatments that can significantly enhance patient quality of life, showcasing the importance of continued research and development in medical sciences. As she progresses in her career, her contributions will likely inspire further advancements in pain therapy and pharmaceutical compositions.
